Bausch Health Companies Inc (BHC)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE
Market Cap: $3.15B
Last updated: Nov 17, 2026 at 4:17 PM ET
Bausch Health Companies Inc (BHC) Statistics
Bausch Health Companies (BHC) has a market cap of $3.15B and an enterprise value of $21.30B. Its net debt of $18.15B equals 576.01% of its market cap. Its trailing P/E of 1.7x is below its 10-year median of 2.9x.
Total Valuation
Enterprise value is 576.01% above the market cap, as debt exceeds cash.
| Market Cap | $3.15B |
|---|---|
| Enterprise Value | $21.30B |
| Latest price (Nov 17, 2026) | $8.48 |
Key Dates
| Last Earnings Date | Oct 28, 2026 |
|---|---|
| Fiscal Year End | December |
Valuation Ratios
The price to sales ratio is 0.3x. Its year-end P/E ranged from 1.8x to 6.7x from 2016 to 2025.
| P/E Ratio | 1.7x |
|---|---|
| Forward P/E | 1.6x |
| P/S Ratio | 0.3x |
| Forward P/S | 0.3x |
| P/FCF Ratio | 1.7x |
| P/OCF Ratio | 1.4x |
Enterprise Valuation
Counting debt and cash, the company is valued at 8.7x EBITDA and 11.4x free cash flow.
| EV / Sales | 1.9x |
|---|---|
| EV / EBITDA | 8.7x |
| EV / EBIT | 17.5x |
| EV / FCF | 11.4x |
Price Statistics
The stock is up 35.03% over 52 weeks and trades 27.52% above its 50-day average.
| Beta (1Y) | 0.98 |
|---|---|
| 52-Week Change | +35.03% |
| 1-Month Change | +34.18% |
| 3-Month Change | +23.08% |
| 6-Month Change | +59.40% |
| 5-Year Change | -70.80% |
| 10-Year Change | -54.04% |
| Total Return (1Y) | +35.03% |
| Total Return (3Y CAGR) | +7.11% |
| Total Return (5Y CAGR) | -20.20% |
| Return vs SPY (1Y) | +25.66% |
| Max Drawdown (1Y) | -43.92% |
| Max Drawdown (3Y) | -59.28% |
| Sharpe Ratio (1Y) | 0.54 |
| Correlation with SPY (1Y) | 0.23 |
| 50-Day Average | $6.65 |
| 200-Day Average | $5.82 |
| 52-Week Range | $4.33 to $9.04 |
| RSI (14 Days) | 67.6 |
| Average Volume (20 Days) | 4.93M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.56x current liabilities.
| Current Ratio | 1.56x |
|---|---|
| Quick Ratio | 1.22x |
| Debt / EBITDA | 8.46x |
| Debt / FCF | 11.07x |
| Interest Coverage | 0.75x |
Returns and Efficiency
Return on invested capital is 6.30% over the last 12 months, against a 5-year average of 3.76%.
| Return on Assets (ROA) | -3.25% |
|---|---|
| Return on Invested Capital (ROIC) | 6.30% |
| Return on Capital Employed (ROCE) | 5.87% |
| ROA (5Y Average) | -1.22% |
| ROIC (5Y Average) | 3.76% |
| Asset Turnover | 0.42x |
| Inventory Turnover | 1.91x |
| Receivables Turnover | 4.63x |
| Cash Conversion Cycle | 204 days |
Scores
BHC has an Altman Z-Score of 0.22, in the distress zone below 1.81, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 0.22 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $11.11B over the last 12 months is up 10.81% from the 12 months before.
| Revenue | $11.11B |
|---|---|
| Revenue Growth (YoY) | +10.81% |
| Gross Profit | $8.07B |
| Operating Income | $1.25B |
| Pretax Income | -$353.00M |
| Net Income | -$828.00M |
| EBITDA | $2.44B |
| EBIT | $1.22B |
| Reported EPS (TTM) | $4.89 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
| Cash and Equivalents | $2.48B |
|---|---|
| Total Debt | $20.64B |
| Net Debt | $18.15B |
| Net Debt Per Share | $48.34 |
| Working Capital | $2.66B |
| Shareholder Equity | -$1.33B |
| Tangible Book Value | -$15.07B |
| Total Assets | $25.48B |
| Total Liabilities | $25.82B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $344.00M of capital spending, operating cash flow left $1.86B of free cash flow.
| Operating Cash Flow | $2.21B |
|---|---|
| Capital Expenditures | $344.00M |
| Free Cash Flow | $1.86B |
| FCF Per Share | $4.99 |
| Depreciation and Amortization | $1.22B |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 11.22%, against a 5-year average of 11.13%.
| Gross Margin | 72.62% |
|---|---|
| Operating Margin | 11.22% |
| Pretax Margin | -3.18% |
| Net Margin | -7.45% |
| EBITDA Margin | 21.96% |
| EBIT Margin | 10.95% |
| FCF Margin | 16.78% |
| Gross Margin (5Y Average) | 71.01% |
| Operating Margin (5Y Average) | 11.13% |
| Net Margin (5Y Average) | -4.06% |
Growth
Revenue grew 8.11% a year over 3 years, and EPS 7.11% a year.
| Revenue Growth (3Y CAGR) | +8.11% |
|---|---|
| EPS Growth (3Y CAGR) | +7.11% |
| EPS Growth (5Y CAGR) | -1.18% |
| FCF Growth (5Y CAGR) | +4.39% |
| Operating Income Growth (3Y CAGR) | +58.65% |
Dividends and Yields
BHC does not pay a dividend. Its free cash flow yield is 58.57%.
| Earnings Yield | 58.82% |
|---|---|
| FCF Yield | 58.57% |
| Shareholder Yield | 0.00% |
Peer Position
Against 10 similar companies, BHC has the lowest P/E.
P/E RatioPeer median 11.8x
P/S RatioPeer median 2.0x
ROICPeer median 11.69%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +13.23%
| P/E Ratio | 1.7x vs 11.8x median |
|---|---|
| P/S Ratio | 0.3x vs 2.0x median |
| ROIC | 6.30% vs 11.69% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +10.81% vs +13.23% median |
Analyst Forecast
Consensus estimates put revenue growth at 3.30% and EPS growth at 7.43% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +3.30% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +7.43% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About BHC
What is BHC's market cap?
Bausch Health Companies has a market cap of $3.15B. Its enterprise value, which adds debt and subtracts cash, is $21.30B.
What is BHC's P/E ratio?
Bausch Health Companies has a trailing P/E ratio of 1.7x and a forward P/E of 1.6x.
How many shares of BHC are outstanding?
Bausch Health Companies has 375.50M shares outstanding. The count is up 1.13% from a year earlier.
Does BHC pay a dividend?
No. Bausch Health Companies does not pay a dividend.
How much debt does BHC have?
Bausch Health Companies has $20.64B of total debt and $2.48B of cash and equivalents, a net debt position of $18.15B.
BHC pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors